Showing 2311-2320 of 19322 results for "".
Dr. Mütter's Marvels: A True Tale of Intrigue and Innovation at the Dawn of Modern Medicine
https://reachmd.com/programs/book-club/dr-mutters-marvels-true-tale-intrigue-innovation-dawn-modern-medicine/7620/Dr. Thomas Dent Mütter was an audacious medical innovator who pioneered the use of ether as anesthesia, the sterilization of surgical tools, and a compassion-based vision for helping the severely deformed, which clashed spectacularly with the sentiments of his time in the mid 19th century. Cristin OAmerican College of Physician Policy Recommendations for Reducing Gun-Related Injuries and Deaths in the U.S.
https://reachmd.com/programs/clinicians-roundtable/american-college-of-physician-policy-recommendations-for-reducing-gun-related-injuries-and-deaths-in-the-us/7036/Gun violence continues to be a major health care issue. What can physicians and other health care providers do to reduce firearms-related violence? Host Dr. Maurice Pickard welcomes Dr. David Fleming, the 2014-2015 President of the American College of Physicians (ACP), the nation's largest medical sThe Witch in the Waiting Room: A Physician Investigates Paranormal Phenomena in Medicine
https://reachmd.com/programs/book-club/ithe-witch-in-the-waiting-room-a-physician-investigates-paranormal-phenomena-in-medicinei/7031/These rare and unexplainable instances don’t fit into the normal lexicon of medical diagnoses.Antiplatelet Therapy After Drug-Eluting Stent Implantation
https://reachmd.com/programs/heart-matters/antiplatelet-therapy-after-drug-eluting-stent-implantation/3959/It is no longer a question of whether antiplatelet therapy should be used following implantation of a drug-eluting stent, but rather to what extent and to what duration. With this in mind, many new challenges arise, from bleeding risks to drug intolerance and product cost. Host Dr. Doug Weaver welcoInvestigational Approaches to Structural and Valvular Heart Disease
https://reachmd.com/programs/medical-breakthroughs-from-penn-medicine/investigational-approaches-to-structural-and-valvular-heart-disease/3442/We are increasingly able to turn to non-surgical therapies for structural and valvular heart disease. Host Dr. Lee Freedman discusses investigational, catheter-based treatment with Dr. Howard Herrmann, professor of medicine, and director of interventional cardiology and the Cardiac Catheterization LHelping Patients Deal with the Psychosocial Issues of Huntington's Disease
https://reachmd.com/programs/clinicians-roundtable/helping-patients-deal-with-the-psychosocial-issues-of-huntingtons-disease/3074/Dr. Robert Klitzman, associate professor of clinical psychology at Columbia University, discusses how to prepare patients and their families to deal with the complex issues that arise in families that have inherited Huntington's disease. Join host Dr. Maurice Pickard for this important discussion.Incorporating Spirituality into Medical Practice
https://reachmd.com/programs/clinicians-roundtable/incorporating-spirituality-into-medical-practice/2786/How can we address the formless notion of spirituality in the exam room? Moving beyond religion, Dr. Christina Puchalski, internist, and Director of the George Washington Institute for Spirituality in Health, and Associate Professor of Medicine and Health Sciences at George Washington University spePharma and Biotech Industries Pursue Treatments for Cardiac Inflammation
https://reachmd.com/programs/clinicians-roundtable/pharma-and-biotech-industries-pursue-treatments-for-cardiac-inflammation/3660/A treatment for atherosclerosis and the chronic inflammation in arterial blood vessels could be entering critical clinical trial stages that may result in a novel new treatment. Dr. Lawrence Cohen, president and chief executive officer of VIA Pharmaceuticals lays out for host ChiManaging Insulin-Resistant Patients With Multiple Risk Factors
https://reachmd.com/programs/lipid-luminations/managing-insulin-resistant-patients-with-multiple-risk-factors/3323/Host Dr. Larry Kaskel welcomes Dr. Yehuda Handelsman, medical director of the Metabolic Institute of America and chair of the International Committee for Insulin Resistance. Dr. Handelsman examines the relationship of insulin resistance to metabolic syndrome, as well as a series of clinical conditioThe ARBITER 6-HALTS Trial: Clinical Implications
https://reachmd.com/programs/heart-matters/the-arbiter-6-halts-trial-clinical-implications/4990/Previous trials, including the ENHANCE trial, have raised doubts about the clinical benefits of adding ezetimibe to high-dose statin therapy. The ARBITER 6-HALTS trial added further weight to the results of ENHANCE, wherein the ARBITER trial demonstrated that extended-release niacin was superior to